Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Kushi Kullar who wrote (29719)	12/22/1999 7:06:00 PM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 32384

Who are they getting poor reviews from? Just curious... It seems to me they aren't doing too badly. Strangely enough, the company would probably have been valued higher if they'd had fewer products in the pipeline. One thing I find interesting is that there doesn't seem to be any mention of products beyond Targretin any longer. But we know that they have quite a few other compounds so they are clearly working to focus everyone's attention. Thanks, Torben